Index by author
Boockvar, J.A.
- ADULT BRAINOpen AccessDynamic Susceptibility Contrast-Enhanced MR Perfusion Imaging in Assessing Recurrent Glioblastoma Response to Superselective Intra-Arterial Bevacizumab TherapyR. Singh, K. Kesavabhotla, S.A. Kishore, Z. Zhou, A.J. Tsiouris, C.G. Filippi, J.A. Boockvar and I. KovanlikayaAmerican Journal of Neuroradiology October 2016, 37 (10) 1838-1843; DOI: https://doi.org/10.3174/ajnr.A4823
Booth, T.N.
- PEDIATRICSYou have accessMR Imaging of the Cervical Spine in Nonaccidental Trauma: A Tertiary Institution ExperienceR. Jacob, M. Cox, K. Koral, C. Greenwell, Y. Xi, L. Vinson, K. Reeder, B. Weprin, R. Huang and T.N. BoothAmerican Journal of Neuroradiology October 2016, 37 (10) 1944-1950; DOI: https://doi.org/10.3174/ajnr.A4817
Boto, J.
- You have accessSynthetic MR Imaging Sequence in Daily Clinical PracticeM.I. Vargas, J. Boto and B.M. DelatreAmerican Journal of Neuroradiology October 2016, 37 (10) E68-E69; DOI: https://doi.org/10.3174/ajnr.A4895
Botta, D.
- EDITOR'S CHOICEINTERVENTIONALYou have accessOcular Signs Caused by Dural Arteriovenous Fistula without Involvement of the Cavernous Sinus: A Case Series with Review of the LiteratureT. Robert, D. Botta, R. Blanc, R. Fahed, G. Ciccio, S. Smajda, H. Redjem and M. PiotinAmerican Journal of Neuroradiology October 2016, 37 (10) 1870-1875; DOI: https://doi.org/10.3174/ajnr.A4831
Ocular signs are unusual in the presentation of cranial dural arteriovenous fistulas in locations other than the cavernous sinus. Between 2000–2015, 13 patients met the inclusion criteria for this retrospective analysis. The most common signs were chemosis (61.5%), loss of visual acuity (38.5%), exophthalmia (38.5%), and ocular hypertension (7.7%). Dural arteriovenous fistulas presenting with ocular signs were classified into 4 types due to their pathologic mechanism (local venous reflux into the superior ophthalmic vein, massive venous engorgement of the cerebrum responsible for intracranial hypertension, compression of an oculomotor nerve by a venous dilation, or intraorbital fistula with drainage into the superior ophthalmic vein).
Bourdain, F.
- INTERVENTIONALYou have accessA Direct Aspiration, First Pass Technique (ADAPT) versus Stent Retrievers for Acute Stroke Therapy: An Observational Comparative StudyB. Lapergue, R. Blanc, P. Guedin, J.-P. Decroix, J. Labreuche, C. Preda, B. Bartolini, O. Coskun, H. Redjem, M. Mazighi, F. Bourdain, G. Rodesch and M. PiotinAmerican Journal of Neuroradiology October 2016, 37 (10) 1860-1865; DOI: https://doi.org/10.3174/ajnr.A4840
Branstetter, B.F.
- HEAD & NECKYou have accessThe CT Prevalence of Arrested Pneumatization of the Sphenoid Sinus in Patients with Sickle Cell DiseaseA.V. Prabhu and B.F. BranstetterAmerican Journal of Neuroradiology October 2016, 37 (10) 1916-1919; DOI: https://doi.org/10.3174/ajnr.A4801
- EDITOR'S CHOICEHEAD & NECKYou have accessImaging Appearance of SMARCB1 (INI1)-Deficient Sinonasal Carcinoma: A Newly Described Sinonasal MalignancyD.R. Shatzkes, L.E. Ginsberg, M. Wong, A.H. Aiken, B.F. Branstetter, M.A. Michel and N. AygunAmerican Journal of Neuroradiology October 2016, 37 (10) 1925-1929; DOI: https://doi.org/10.3174/ajnr.A4841
SMARCB1 (INI1) is a tumor-suppressor gene that has been implicated in a growing number of malignancies involving multiple anatomic sites, including the kidneys, soft tissues, and the CNS (See OMIM *601607). The authors describe a case series of 17 patients collected from 6 different centers to give a comprehensive description of the appearance of these tumors on CT, MR, and PET/CT studies. SMARCB1 (INI1)-deficient sinonasal carcinoma should be included in the differential diagnosis of a central sinonasal mass demonstrating aggressive imaging features, particularly when there is associated calcification.
Brinjikji, W.
- FELLOWS' JOURNAL CLUBINTERVENTIONALYou have accessFlow Diversion for Ophthalmic Artery AneurysmsA.M. Burrows, W. Brinjikji, R.C. Puffer, H. Cloft, D.F. Kallmes and G. LanzinoAmerican Journal of Neuroradiology October 2016, 37 (10) 1866-1869; DOI: https://doi.org/10.3174/ajnr.A4835
This is a retrospective review of 48 patients with 50 carotid-ophthalmic aneurysms in which 44 patients with 46 aneurysms were treated with flow diversion from June 2009 to June 2015. There were no permanent adverse visual outcomes. There was 1 death due to late intraparenchymal hemorrhage (2.2%). Six-month angiography showed complete occlusion in 24 of 37 patients (64.9%), and 3-year angiography results showed occlusion in 24 of 25 patients (96%).
Brouwers, H.B.
- ADULT BRAINOpen AccessEffect of CTA Tube Current on Spot Sign Detection and Accuracy for Prediction of Intracerebral Hemorrhage ExpansionA. Morotti, J.M. Romero, M.J. Jessel, H.B. Brouwers, R. Gupta, K. Schwab, A. Vashkevich, A. Ayres, C.D. Anderson, M.E. Gurol, A. Viswanathan, S.M. Greenberg, J. Rosand and J.N. GoldsteinAmerican Journal of Neuroradiology October 2016, 37 (10) 1781-1786; DOI: https://doi.org/10.3174/ajnr.A4810
Burrows, A.M.
- FELLOWS' JOURNAL CLUBINTERVENTIONALYou have accessFlow Diversion for Ophthalmic Artery AneurysmsA.M. Burrows, W. Brinjikji, R.C. Puffer, H. Cloft, D.F. Kallmes and G. LanzinoAmerican Journal of Neuroradiology October 2016, 37 (10) 1866-1869; DOI: https://doi.org/10.3174/ajnr.A4835
This is a retrospective review of 48 patients with 50 carotid-ophthalmic aneurysms in which 44 patients with 46 aneurysms were treated with flow diversion from June 2009 to June 2015. There were no permanent adverse visual outcomes. There was 1 death due to late intraparenchymal hemorrhage (2.2%). Six-month angiography showed complete occlusion in 24 of 37 patients (64.9%), and 3-year angiography results showed occlusion in 24 of 25 patients (96%).
In this issue
